Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis

[1] Guariguata L(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-149

[2] Whiting DR(2016)Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making Fam Pract 33 401-407

[3] Hambleton I(2007)Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis Epidemiol Rev 29 115-128

[4] Beagley J(2002)The association between components of adult height and Type II diabetes and insulin resistance: British Women’s Heart and Health Study Diabetologia 45 1097-1106

[5] Linnenkamp U(2016)Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications Lancet Diabetes Endocrinol 4 457-467

[6] Shaw JE(2007)A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 1341-1345

[7] Guo VY(2007)A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 881-885

[8] Yu EY(2016)Phenotypes of prediabetes and stratification of cardiometabolic risk Lancet Diabetes Endocrinol 4 789-798

[9] Wong C(2011)Risk models and scores for type 2 diabetes: systematic review BMJ 343 d7163-1455

[10] Vazquez G(1993)Serum alpha(2)-Hs-glycoprotein is an inhibitor of the human insulin-receptor at the tyrosine kinase level Mol Endocrinol 7 1445-640

[1] Guariguata L(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-149

[2] Whiting DR(2016)Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making Fam Pract 33 401-407

[3] Hambleton I(2007)Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis Epidemiol Rev 29 115-128

[4] Beagley J(2002)The association between components of adult height and Type II diabetes and insulin resistance: British Women’s Heart and Health Study Diabetologia 45 1097-1106

[5] Linnenkamp U(2016)Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications Lancet Diabetes Endocrinol 4 457-467

[6] Shaw JE(2007)A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 1341-1345

[7] Guo VY(2007)A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 881-885

[8] Yu EY(2016)Phenotypes of prediabetes and stratification of cardiometabolic risk Lancet Diabetes Endocrinol 4 789-798

[9] Wong C(2011)Risk models and scores for type 2 diabetes: systematic review BMJ 343 d7163-1455

[10] Vazquez G(1993)Serum alpha(2)-Hs-glycoprotein is an inhibitor of the human insulin-receptor at the tyrosine kinase level Mol Endocrinol 7 1445-640